DUBLIN--(BUSINESS WIRE)--Jun 8, 2018--The "Global Human Vaccines Market - Technologies, Market share and Industry Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

Global human vaccines market is expected to rise with a CAGR of 11.3% during forecast period 2017-2024.

Key factors driving the market growth are growing awareness regarding vaccination and immunization program, surging demand for pediatric vaccines, rising prevalence of infectious diseases and improving healthcare infrastructure. Stringent regulatory process and adverse side effects of vaccines are expected to restrain the market growth. However, increase in investment for human vaccines and emergence of novel vaccines and resistant strains are expected to provide lucrative market opportunities. Vaccine storage and handling issues and inadequate vaccination coverage is expected to challenge the market growth.

Geographically, global human vaccines is segmented into North America, Europe, Asia Pacific and RoW. North America is the leading region for global human vaccines market in terms of market revenue share in 2017. This is due to the increasing number of regulatory approvals of human vaccines in U.S., Canada, etc., surging demand for vaccination among adults and children, increase in government efforts toward vaccination programs, etc. are expected to fuel the growth of North America human vaccines market.

Global human vaccines market report covers segmentation analysis of vaccine type, product, age group and distribution channel. On the basis of vaccines types, market is segmented into conjugate vaccine, recombinant vaccine, inactivated vaccine, combination vaccine, attenuated vaccine and others vaccine. Conjugate vaccines is the leading vaccine type segment due to the increased adoption of conjugate vaccines for adults, technological advancements in conjugate vaccines, regulatory approvals for regulatory vaccines, etc.

Companies Mentioned

Abbott Laboratories (U.S.) Astrazeneca Plc (U.K.) Bavarian Nordic (Denmark) Bio Med (U.K.) Dynavax Technologies (U.S.) Glaxosmithkline Plc (U.K.) Johnson & Johnson (U.S.) Lupin (India) Merck & Co. Inc. (U.S.) Novartis (Switzerland) Panacea Biotec (India) Pfizer Inc. (U.S.) Sanofi (France) Takeda Pharmaceutical (Japan) Zydus Cadila (India)

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Global Human Vaccines Market By Vaccine Type

5. Global Human Vaccines Market By Product

6. Global Human Vaccines Market By Age Group

7. Global Human Vaccines Market By Distribution Channel

8. Competitive Landscape

9. Geographic Analysis

10. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/szh8kh/global_human?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180608005242/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Vaccines

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/08/2018 06:14 AM/DISC: 06/08/2018 06:14 AM

http://www.businesswire.com/news/home/20180608005242/en